Subsidiary Guarantors Condensed Consolidating Statement of Cash Flows (Details) - USD ($) shares in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 1,356.5	$ 888.2
Cash flows from investing activities:
Capital expenditures	(207.3)	(220.3)
Cash paid for acquisitions, net	0.0	(50.0)
Proceeds from sale of property, plant and equipment	2.3	8.8
Purchase of marketable securities	(59.1)	(17.6)
Proceeds from sale of marketable securities	29.4	16.4
Investments in affiliates	0.0	0.0
Loans to affiliates	0.0	0.0
Repayments of loans from affiliates	0.0	0.0
Payments for product rights and other, net	(404.6)	(454.2)
Net cash used in investing activities	(639.3)	(716.9)
Cash flows from financing activities:
Payment of financing fees	(114.7)	(2.4)
Change in short-term borrowings, net	(329.7)	(75.1)
Proceeds from convertible note hedge	1,970.8	0.0
Proceeds from issuance of long-term debt	2,390.0	635.0
Payment of long-term debt	(4,334.1)	(695.0)
Proceeds from exercise of stock options	92.8	34.2
Taxes paid related to net share settlement of equity awards	(31.7)	(22.8)
Payments for contingent consideration	0.0	(150.0)
Capital contribution from affiliates	0.0	0.0
Payments on borrowings from affiliates	0.0	0.0
Proceeds from borrowings from affiliates	0.0	0.0
Acquisition of noncontrolling interest	(11.7)	0.0
Other items, net	49.6	22.4
Net cash used in financing activities	(318.7)	(253.7)
Effect of Exchange Rate on Cash and Cash Equivalents	(37.0)	(9.3)
Net increase (decrease) in cash and cash equivalents	361.5	(91.7)
Cash and cash equivalents — beginning of period	225.5	291.3
Cash and cash equivalents — end of period	$ 587.0	$ 199.6
Non-cash transaction:
Ordinary shares issued for acquisition	6,305.8	0.0
Eliminations
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 0.0	$ 0.0
Cash flows from investing activities:
Capital expenditures	0.0	0.0
Cash paid for acquisitions, net		0.0
Proceeds from sale of property, plant and equipment	0.0	0.0
Purchase of marketable securities	0.0	0.0
Proceeds from sale of marketable securities	0.0	0.0
Investments in affiliates	289.4	49.0
Loans to affiliates	9,946.9	7,648.0
Repayments of loans from affiliates	(263.1)	(8.2)
Payments for product rights and other, net	0.0	0.0
Net cash used in investing activities	9,973.2	7,688.8
Cash flows from financing activities:
Payment of financing fees	0.0	0.0
Change in short-term borrowings, net	0.0	0.0
Proceeds from convertible note hedge	0.0
Proceeds from issuance of long-term debt	0.0	0.0
Payment of long-term debt	0.0	0.0
Proceeds from exercise of stock options	0.0	0.0
Taxes paid related to net share settlement of equity awards	0.0	0.0
Payments for contingent consideration		0.0
Capital contribution from affiliates	(289.4)	(49.0)
Payments on borrowings from affiliates	263.1	(7,648.0)
Proceeds from borrowings from affiliates	(9,946.9)	8.2
Acquisition of noncontrolling interest	0.0
Other items, net	0.0	0.0
Net cash used in financing activities	(9,973.2)	(7,688.8)
Effect of Exchange Rate on Cash and Cash Equivalents	0.0	0.0
Net increase (decrease) in cash and cash equivalents	0.0	0.0
Cash and cash equivalents — beginning of period	0.0	0.0
Cash and cash equivalents — end of period	$ 0.0	0.0
Non-cash transaction:
Ordinary shares issued for acquisition	0.0
Mylan N.V. (Parent Guarantor)
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 0.0
Cash flows from investing activities:
Capital expenditures	0.0
Proceeds from sale of property, plant and equipment	0.0
Purchase of marketable securities	0.0
Proceeds from sale of marketable securities	0.0
Investments in affiliates	0.0
Loans to affiliates	(39.5)
Repayments of loans from affiliates	0.0
Payments for product rights and other, net	0.0
Net cash used in investing activities	(39.5)
Cash flows from financing activities:
Payment of financing fees	(89.1)
Change in short-term borrowings, net	0.0
Proceeds from convertible note hedge	0.0
Proceeds from issuance of long-term debt	0.0
Payment of long-term debt	0.0
Proceeds from exercise of stock options	39.5
Taxes paid related to net share settlement of equity awards	0.0
Capital contribution from affiliates	0.0
Payments on borrowings from affiliates	0.0
Proceeds from borrowings from affiliates	89.1
Acquisition of noncontrolling interest	0.0
Other items, net	1.3
Net cash used in financing activities	40.8
Effect of Exchange Rate on Cash and Cash Equivalents	0.0
Net increase (decrease) in cash and cash equivalents	1.3
Cash and cash equivalents — beginning of period	0.1
Cash and cash equivalents — end of period	$ 1.4
Non-cash transaction:
Ordinary shares issued for acquisition	6,305.8
Mylan Inc. (Issuer)
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ (1,417.1)	(686.3)
Cash flows from investing activities:
Capital expenditures	(55.1)	(57.5)
Cash paid for acquisitions, net		0.0
Proceeds from sale of property, plant and equipment	0.0	0.0
Purchase of marketable securities	(29.3)	(2.7)
Proceeds from sale of marketable securities	0.0	0.0
Investments in affiliates	(289.4)	(49.0)
Loans to affiliates	(4,250.1)	(3,301.9)
Repayments of loans from affiliates	240.6	0.3
Payments for product rights and other, net	0.0	(11.3)
Net cash used in investing activities	(4,383.3)	(3,422.1)
Cash flows from financing activities:
Payment of financing fees	(25.6)	(2.4)
Change in short-term borrowings, net	0.0	0.0
Proceeds from convertible note hedge	1,970.8
Proceeds from issuance of long-term debt	2,390.0	635.0
Payment of long-term debt	(4,334.1)	(695.0)
Proceeds from exercise of stock options	53.3	34.2
Taxes paid related to net share settlement of equity awards	(25.8)	(17.3)
Payments for contingent consideration		(150.0)
Capital contribution from affiliates	0.0	0.0
Payments on borrowings from affiliates	(22.5)	4,346.1
Proceeds from borrowings from affiliates	5,696.8	(7.9)
Acquisition of noncontrolling interest	0.0
Other items, net	48.3	22.4
Net cash used in financing activities	5,751.2	4,165.1
Effect of Exchange Rate on Cash and Cash Equivalents	0.0	0.0
Net increase (decrease) in cash and cash equivalents	(49.2)	56.7
Cash and cash equivalents — beginning of period	112.9	14.4
Cash and cash equivalents — end of period	$ 63.7	71.1
Non-cash transaction:
Ordinary shares issued for acquisition	0.0
Guarantor Subsidiaries
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 0.0	0.0
Cash flows from investing activities:
Capital expenditures	0.0	0.0
Cash paid for acquisitions, net		0.0
Proceeds from sale of property, plant and equipment	0.0	0.0
Purchase of marketable securities	0.0	0.0
Proceeds from sale of marketable securities	0.0	0.0
Investments in affiliates	0.0	0.0
Loans to affiliates	0.0	0.0
Repayments of loans from affiliates	0.0	0.0
Payments for product rights and other, net	0.0	0.0
Net cash used in investing activities	0.0	0.0
Cash flows from financing activities:
Payment of financing fees	0.0	0.0
Change in short-term borrowings, net	0.0	0.0
Proceeds from convertible note hedge	0.0
Proceeds from issuance of long-term debt	0.0	0.0
Payment of long-term debt	0.0	0.0
Proceeds from exercise of stock options	0.0	0.0
Taxes paid related to net share settlement of equity awards	0.0	0.0
Payments for contingent consideration		0.0
Capital contribution from affiliates	0.0	0.0
Payments on borrowings from affiliates	0.0	0.0
Proceeds from borrowings from affiliates	0.0	0.0
Acquisition of noncontrolling interest	0.0
Other items, net	0.0	0.0
Net cash used in financing activities	0.0	0.0
Effect of Exchange Rate on Cash and Cash Equivalents	0.0	0.0
Net increase (decrease) in cash and cash equivalents	0.0	0.0
Cash and cash equivalents — beginning of period	0.0	0.0
Cash and cash equivalents — end of period	$ 0.0	0.0
Non-cash transaction:
Ordinary shares issued for acquisition	0.0
Non-Guarantor Subsidiaries
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 2,773.6	1,574.5
Cash flows from investing activities:
Capital expenditures	(152.2)	(162.8)
Cash paid for acquisitions, net		(50.0)
Proceeds from sale of property, plant and equipment	2.3	8.8
Purchase of marketable securities	(29.8)	(14.9)
Proceeds from sale of marketable securities	$ 29.4	16.4
Investments in affiliates		0.0
Loans to affiliates	$ (5,657.3)	(4,346.1)
Repayments of loans from affiliates	22.5	7.9
Payments for product rights and other, net	(404.6)	(442.9)
Net cash used in investing activities	(6,189.7)	(4,983.6)
Cash flows from financing activities:
Payment of financing fees	0.0	0.0
Change in short-term borrowings, net	(329.7)	(75.1)
Proceeds from convertible note hedge	0.0
Proceeds from issuance of long-term debt	0.0	0.0
Payment of long-term debt	0.0	0.0
Proceeds from exercise of stock options	0.0	0.0
Taxes paid related to net share settlement of equity awards	(5.9)	(5.5)
Payments for contingent consideration		0.0
Capital contribution from affiliates	289.4	49.0
Payments on borrowings from affiliates	(240.6)	3,301.9
Proceeds from borrowings from affiliates	4,161.0	(0.3)
Acquisition of noncontrolling interest	(11.7)
Other items, net	0.0	0.0
Net cash used in financing activities	3,862.5	3,270.0
Effect of Exchange Rate on Cash and Cash Equivalents	(37.0)	(9.3)
Net increase (decrease) in cash and cash equivalents	409.4	(148.4)
Cash and cash equivalents — beginning of period	112.5	276.9
Cash and cash equivalents — end of period	$ 521.9	$ 128.5
Non-cash transaction:
Ordinary shares issued for acquisition	0.0